| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/25/2004 | WO2004024152A1 Stable cream preparations of phenyl-pyridone compounds for topical application |
| 03/25/2004 | WO2004024138A1 Solid preparation containing dioctyl sodium sulfosuccinate |
| 03/25/2004 | WO2004024134A1 Pharmaceutical formulations of modafinil |
| 03/25/2004 | WO2004024133A1 Novel pharmaceutical formulations of modafinil |
| 03/25/2004 | WO2004024128A2 Modified release ketoprofen dosage form |
| 03/25/2004 | WO2004024127A2 Solid formulations comprising an indolinone compound |
| 03/25/2004 | WO2004024126A1 Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin |
| 03/25/2004 | WO2004024125A1 Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same |
| 03/25/2004 | WO2004024124A1 Modified release oral dosage form |
| 03/25/2004 | WO2004024123A1 Accelerating recovery from trauma |
| 03/25/2004 | WO2004024122A1 Composition and method for moisturizing nasal tissue |
| 03/25/2004 | WO2004024121A2 Methods of measuring the dissolution rates of an analyte in a non-aqueous liquid composition |
| 03/25/2004 | WO2004024111A1 Pectin films |
| 03/25/2004 | WO2004024057A1 Process for producing seamless capsule quickly dissolving in the oral cavity |
| 03/25/2004 | WO2004024056A1 Process for the production of microspheres and unit therefor |
| 03/25/2004 | WO2004023979A2 Mucus formulation for mucosal surfaces and uses thereof |
| 03/25/2004 | WO2004023896A1 Infant formula |
| 03/25/2004 | WO2004016303A9 Threaded syringe with quick stop |
| 03/25/2004 | WO2004012701A3 NOVEL pH DEPENDENT ROBUST ENTERIC POLYMERIC CONTAINER, AN IMPROVEMENT OVER EXISTING ENTERIC DOSAGE FORMS. |
| 03/25/2004 | WO2004006954A3 Transdermal botulinum toxin compositions |
| 03/25/2004 | WO2004002320A3 Device and method for combining a treatment agent and a gel |
| 03/25/2004 | WO2004000849A3 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity |
| 03/25/2004 | WO2004000388A3 Promotional simulation for transdermal patch sampler |
| 03/25/2004 | WO2004000358B1 Transdermal drug delivery system |
| 03/25/2004 | WO2004000289A3 Preparations for the intranasal application of selected cgrp antagonists derived from amino acids and a method for their production |
| 03/25/2004 | WO2003105890A3 Vaccine comprising mixtures of multivalent meningococcal outer membrane vesciles |
| 03/25/2004 | WO2003105826B1 "soluble stable pharmaceutical composition for the administration of hiv protease inhibitors and a process for the preparation of concentrated pharmaceutical compositions for the administration of hiv protease inhibitors." |
| 03/25/2004 | WO2003105780A3 A dry powder oligonucleotide formulation, preparation and its uses |
| 03/25/2004 | WO2003103822A3 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s) |
| 03/25/2004 | WO2003103603A3 Novel formate salt of o-desmethyl-venlafaxine |
| 03/25/2004 | WO2003101434A3 Intranasal pharmaceutical compositions comprising an antihistamine and a leukotriene inhibitor |
| 03/25/2004 | WO2003092640A3 Cosmetic product comprising at least one water-soluble copolymer which contains (meth)acrylamide units |
| 03/25/2004 | WO2003092591A3 Multi-phasic delivery via transmucosal absorption of antiemetic medicaments |
| 03/25/2004 | WO2003090726A3 Chewable soft capsule |
| 03/25/2004 | WO2003086392A3 Process for preparing a finely self-emulsifiable pharmaceutical composition |
| 03/25/2004 | WO2003086326A3 G-type peptides to ameliorate atherosclerosis |
| 03/25/2004 | WO2003077842A3 Palatable oral suspension and method |
| 03/25/2004 | WO2003075898A3 Film coatings with controlled release and high stability |
| 03/25/2004 | WO2003072195A3 Method for administering glp-1 molecules |
| 03/25/2004 | WO2003072060A3 Polypeptide formulation |
| 03/25/2004 | WO2003070735A3 Components for producing amphoteric liposomes |
| 03/25/2004 | WO2003070213A3 Liquid mucoadhesive pharmaceutical composition |
| 03/25/2004 | WO2003059318A3 Medicated tampon |
| 03/25/2004 | WO2003055590A3 Switchable surfaces |
| 03/25/2004 | WO2003039519A3 Dual controlled release dosage form |
| 03/25/2004 | WO2003028645A3 Novel compositions of carvedilol |
| 03/25/2004 | WO2003028633A3 Parenteral delivery systems |
| 03/25/2004 | WO2003011008A3 Therapeutic delivery compositions and methods of use thereof |
| 03/25/2004 | WO2003000343A3 Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
| 03/25/2004 | WO2002039998A3 Methods and compositions for regulating memory consolidation |
| 03/25/2004 | US20040059408 Polymer compositions for intraluminal stent |
| 03/25/2004 | US20040059316 Medical delivery device |
| 03/25/2004 | US20040059315 Programmable dose control module |
| 03/25/2004 | US20040059295 Rapid infusion system |
| 03/25/2004 | US20040059281 Delivery system and method of treating or preventing otitis media |
| 03/25/2004 | US20040059066 Injections for endoscopy |
| 03/25/2004 | US20040059002 Sustained release delivery of amphetamine salts |
| 03/25/2004 | US20040059001 Extended release pharmaceutical composition containing metformin |
| 03/25/2004 | US20040058994 Local prevention or amelioration of pain from surgically closed wounds |
| 03/25/2004 | US20040058989 Solid dosage form; antidepressant |
| 03/25/2004 | US20040058981 Administering free radical generators such as artemisinim, arteflene |
| 03/25/2004 | US20040058973 Therapy for sleep disorders; administering orally |
| 03/25/2004 | US20040058967 Crystalline organic acid salt of amlodipine |
| 03/25/2004 | US20040058966 Method for reducing or eliminating smoking |
| 03/25/2004 | US20040058956 Oral absorption; bioavailability of antiproliferative agent |
| 03/25/2004 | US20040058946 Abuse-resistant prodrugs of oxycodone and other pharmaceuticals |
| 03/25/2004 | US20040058935 Crystals; storage stability; psychological disorders |
| 03/25/2004 | US20040058909 Method of treatment |
| 03/25/2004 | US20040058896 Uniform dispersion in excipient of fatty acid, triglyceride and,or fatty ester |
| 03/25/2004 | US20040058895 Administering by injection; reduction of blood parathyroid hormone |
| 03/25/2004 | US20040058882 Microseeding device for gene delivery by microneedle injection |
| 03/25/2004 | US20040058879 Processes for preparing clarithromycin polymorphs and novel polymorph IV |
| 03/25/2004 | US20040058850 Using caspase inhibitor; antiinflammatory agents |
| 03/25/2004 | US20040058313 Using gabapentim to relieve external pressure and improve glaucoma treatments; neuroprotectants and eye surgery; neurotoxins and vision defects |
| 03/25/2004 | US20040058033 Chewing gum in powder form and a method of preparation |
| 03/25/2004 | US20040058026 Tablets containing heat sensitive materials and method for forming thereof |
| 03/25/2004 | US20040058018 Novel substituted benzimidazole dosage forms and method of using same |
| 03/25/2004 | US20040058011 Comprises chlorhexidine acetate, zinc stearate, and carrier; nontoxic; for domesticated dairy cattle |
| 03/25/2004 | US20040058009 Nanoparticulate fibrate formulations |
| 03/25/2004 | US20040058008 For reducing aggregation; encapsulated by polyanhydrides |
| 03/25/2004 | US20040058007 Such as proteins or polypeptides via anti-solvent under supercritical conditions; water solubility |
| 03/25/2004 | US20040058005 Comprises polyvinylpyrrolidone; for improved bioavailability/ dissolution |
| 03/25/2004 | US20040058004 Suspensions of micronized fenofibrate |
| 03/25/2004 | US20040058002 Expandable osmotic composition and coating suspension |
| 03/25/2004 | US20040058001 For controlled release; drug delivery |
| 03/25/2004 | US20040058000 Controlled release capsule for delivery of liquid formulation |
| 03/25/2004 | US20040057999 Fenofibrate compositions having enhanced bioavailability |
| 03/25/2004 | US20040057998 Granulates of micronized fenofibrate; high bioavailability through improved dissolution |
| 03/25/2004 | US20040057997 Capsules containing fenofibrate compositions |
| 03/25/2004 | US20040057996 Initial release of the bioactive substance is suppressed; matrix containing a bioactive substance and a cationic substance (e.g. benzalkonium chloride or lysine) and/or a polyol such as polyethylene glycol |
| 03/25/2004 | US20040057995 Process for the production of rapidly disintegrating, solid pharmaceutical preparations |
| 03/25/2004 | US20040057993 Rapidly disintegrating solid oral dosage form |
| 03/25/2004 | US20040057992 6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol (laxofoxifene); a prodrug with a glidant, disintegrant, lubricant and diluent/filler in given amounts; unit dosage forms, including low dosage forms |
| 03/25/2004 | US20040057991 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
| 03/25/2004 | US20040057990 Liposomal benzoquinazoline thymidylate synthase inhibitor formulations |
| 03/25/2004 | US20040057989 Method of cancer treatment |
| 03/25/2004 | US20040057988 Dispersing lipids into an aqueous medium to preconstruct vesicles, freeze drying, redispersing vesicles in an aqueous solution of a water soluble substance (hemoglobin), permeating through filter(s); uniform particle size, yield |
| 03/25/2004 | US20040057987 With a permeation enhancer or mixture such as myristyl sarcosine; treatment of acute renal failure |
| 03/25/2004 | US20040057986 Polymerized hydrogel adhesives comprising low amounts of residual monomers |
| 03/25/2004 | US20040057985 With sufficient release rates without needing any enhancer; oxybutynin of the droplet-shaped inner phase will not accumulate at the interfaces and surfaces of the matrix layer if certain polymers are used as pressure sensitive adhesive |